NCT00069082View on ClinicalTrials.gov

Intranasal Civamide for Episodic Cluster Headache

PHASE3CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions
Episodic Cluster Headache
Interventions
DRUG

Civamide (Zucapsaicin)

Nasal Solution 0.01%

DRUG

Sodium Chloride

Nasal Solution 10%

Trial Locations (6)

80218

Colorado Neurology and Headache Clinic, Denver

Unknown

San Francisco Clinical Research Center, San Francisco

California Medical Clinic for Headache, Santa Monica

Diamond Headache Clinic, Chicago

New York Headache Center, New York

Cleveland Clinic Foundation, Cleveland

All Listed Sponsors
lead

Winston Laboratories

INDUSTRY

NCT00069082 - Intranasal Civamide for Episodic Cluster Headache | Biotech Hunter | Biotech Hunter